Ludmila Smolyansky, member of the group of owners of 10% in Lifeway Foods, Inc. (NASDAQ:LWAY), a $330.7 million market cap company with an EXCELLENT financial health rating by InvestingProrecently sold 29,726 shares of the company’s common stock. The transactions, which occurred between January 15 and January 17, 2025, were executed at prices ranging from $22.55 to $22.67 per share, for a total of $671,675. The sale comes after an impressive 71.8% rise in shares over the past six months, with the company maintaining strong fundamentals including a healthy balance sheet with more cash than debt.
After these sales, Smolyansky holds 965,823 shares indirectly through the Ludmila Smolyansky Trust. In addition, she has interests in other entities, including the Ludmila and Edward Smolyansky Family Foundation and the Smolyansky Family Foundation, which together hold additional shares. Transactions are reported on Form 4 filed with the Securities and Exchange Commission. For a deeper insight into the LWAY assessment and more than 10 additional expert tips, visit InvestingProwhere you’ll find comprehensive analysis and an exclusive Pro Research Report.
In other recent news, Lifeway Foods, a well-known purveyor of kefir and fermented probiotic products, has rejected a purchase offer from Danone (EPA:) North America PBC, arguing that the offer significantly undervalues the company. The decision comes on the heels of Lifeway’s impressive track record of 21 consecutive quarters of growth, with revenue rising from $94 million in 2019 to an expected $185.0 million to $186.5 million in 2024. The company’s strong performance was also highlighted by an increase in net sales of 12 .7%. for the third quarter of 2024, reaching USD 46.1 million, largely attributed to its leading beverage product, kefir.
In addition to the financial growth, Lifeway Foods reported a 22% year-to-date sales increase for its kefir product and an improvement in gross profit margins to 25.7% in the quarter. These recent developments underscore Lifeway’s commitment to delivering high-quality, nutritious products and its continued growth momentum.
The company also unveiled expansion plans that include the introduction of new products and increased distribution in international markets. Lifeway’s rejection of Danone’s proposal and its focus on expansion underscore the company’s confidence in its stand-alone business plan. The next update on the company’s performance will be announced during the year-end call.
This article was generated with the help of AI and reviewed by an editor. See our T&C for more information.
